News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Beijing Second Pharmaceutical Wins US Approval for Anti- Hypertensive



5/4/2011 8:38:11 AM

May 3, 2011 -- Beijing Second Pharmaceutical Co. was granted FDA approval for US use of Amlodipine Besylate, a long-acting calcium channel blocker that is prescribed for hypertension and angina. The drug is a generic version of Pfizer’s Norvasc®. According to the company, the approval is the first time the FDA has approved an oral, solid-dose product from a China-owned pharma. BSPC will market the product through a US-based distribution partner. More details....

Stock Symbol: (NYSE: PFE)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES